Table 1.
Studygroup in DiPiS | ||||
---|---|---|---|---|
A | B | C | ||
n | 33 | 18 | 78 | |
Age at diagnosis (yrs) | Mean ±SD | 6.5±2.6 | 7.3±3.2 | 6.5±2.6 |
Gender (n) | Female | 20 (61%) | 9 (50%) | 38 (49%) |
Male | 13 (39%) | 9 (50%) | 40 (51%) | |
HLA-DQ (n) | 2/8 | 15 (46%) | 6 (33%) | 34 (44%) |
8/8, 8/X (X is not 2) | 14 (42%) | 9 (50%) | 18 (23%) | |
2/2, 2/X (X is not 8) | 3 (9%) | 3 (17%) | 15 (19%) | |
X/X (X is not 2 or 8) | 1 (3%) | 0 | 11 (14%) | |
Autoantibody pos. (n) | GAD65A | 24 (73%) | 13 (72%) | 52 (67%) |
IAA-A | 11 (33%) | 8 (44%) | 33 (42%) | |
IA2-A | 28 (85%) | 13 (72%) | 51 (65%) | |
ZnT8RA | 17 (52%) | 8 (44%) | 36 (46%) | |
ZnT8WA | 18 (55%) | 8 (44%) | 29 (37%) | |
ZnT8QA | 12 (36%) | 5 (28%) | 18 (23%) | |
Antibodycount (n) | Negative | 0 | 0 | 2 (3%) |
Single | 4 (12%) | 4 (22%) | 12 (15%) | |
Multiple | 27 (82%) | 14 (78%) | 60 (77%) | |
Missing | 2 (6%) | 0 | 4 (5%) |